Clinical trial
The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With…
NCT00418184 · Enzymotec, Industry · Completed
Key facts
| NCT number | NCT00418184 |
|---|---|
| Title | The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder |
| Official title | A Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder |
| Lead sponsor | Enzymotec, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Attention Deficit/Hyperactivity Disorder (ADHD) |
| Intervention type | Dietary Supplement, Other |
| Interventions | Phosphatidylserine-Omega3, Colored cellulose tainted with fishy odor |
| Enrollment | 200 |
| Start date | Mar 1, 2007 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2009 |
| First posted | Jan 4, 2007 |
| Last update posted | Mar 12, 2014 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: